Short answer: This article explains the key facts, eligibility issues, settlement factors, deadlines, and source-backed updates related to this legal topic. Results vary by case facts, evidence, jurisdiction, and representation.
Breast Implant Recall: What the 2023 Updates Mean for You
The Allergan breast implant recall still affects thousands of people with textured implants, and the 2023 updates added important new information. The main recall dates to 2019, but fresh safety data and cancer reports released during 2023 shifted how doctors and patients think about implant risk.
Key 2023 Updates:
– 19 new reports of squamous cell carcinoma (SCC) in the tissue around breast implants
– 1,264 cases of breast implant-associated lymphoma (BIA-ALCL) reported worldwide
– 63 deaths tied to BIA-ALCL as of June 2023
– A new FDA safety communication in March 2023 on additional cancer risks
The recall mainly involves textured implants, specifically Allergan’s Biocell line: Natrelle saline, Natrelle silicone, Natrelle Inspira and Natrelle 410 models. Their textured surfaces were associated with much higher rates of BIA-ALCL, a rare lymphoma.
The most important point: The FDA does not advise removing recalled implants if you have no symptoms. Patients should still watch for warning signs such as swelling, lumps or fluid around the implant.
One estimate published in 2023 put the BIA-ALCL risk as high as 1 in 2,200 patients with certain textured implants, far above earlier estimates. The cancer typically appears about 8 years after implant surgery, and early detection is associated with a 93% survival rate.
Breast Implant Recall Timeline and Key Facts, 2019-2025
The recall began in July 2019, when the FDA asked Allergan to voluntarily pull its Biocell textured implants. The Class I recall reached more than 4 million implants worldwide after Allergan devices were found in 481 of the 573 BIA-ALCL cases known at the time.
A chain of legal and medical developments followed. Federal cases were consolidated as MDL 2921 to manage thousands of similar claims, and the FDA sent Allergan a warning letter for not finishing required safety studies.
Key Developments Since 2019
The biggest shift came in March 2023, when the FDA released a safety communication on squamous cell carcinoma (SCC) found near breast implants, widening the conversation about implant risk beyond BIA-ALCL.
Reported BIA-ALCL cases rose from 573 in 2019 to 1,264, with 63 deaths, by 2023. FDA data showed 1,130 BIA-ALCL reports as of August 2022, 953 of them involving Allergan implants.
Which Devices Are Affected
The recall covered specific Allergan products: Natrelle saline and Natrelle silicone implants, Natrelle Inspira implants, teardrop-shaped Natrelle 410 implants and 133 Plus tissue expanders.
Surface texture is the key distinction. Textured implants have rough shells meant to grip surrounding tissue, while smooth implants have slick surfaces that appear far safer when it comes to cancer. Only a small number of BIA-ALCL cases worldwide have involved smooth implants, whereas certain textured models showed unacceptably high rates.
What Changed in the 2023 Breast Implant Recall Updates?
The 2023 updates delivered significant news about implant safety. Most notably, in March 2023 the FDA issued a safety communication on squamous cell carcinoma (SCC), a cancer entirely separate from BIA-ALCL.
BIA-ALCL develops in the fluid around an implant, but SCC forms in the scar capsule that grows around every implant, which means people with smooth implants may also be at risk.
The 2023 figures were notable: 19 SCC cases involving 17 women, 1 man and 1 person whose sex was not reported, appearing 7 to 42 years after surgery. BIA-ALCL reports had reached 1,264 worldwide with 63 deaths.
New Research and Risk Figures
Other research calculated 30.54 cases per 100,000 patients with textured implants, roughly 1 in every 3,274 patients, higher than many had assumed.
Across all implant types combined, the rate was 6.70 cases per 100,000 patients, or about 1 in 14,925.
Clear patterns appeared: women older than 46 faced more risk, particularly when implants had been in place longer than 6 years. Macro-textured implants accounted for 73% of BIA-ALCL cases, and cancer appeared an average of 8 years after implantation, with a range of 2 to 32 years.
Other Cancers Being Monitored
SCC is especially worrying because it can occur with any implant type and may take far longer to show up, as much as 42 years after surgery. The FDA broadened reporting requirements and set up the PROFILE registry to track cases.
The FDA’s archived communication on SCC cases highlights how much remains unknown about long-term implant safety.
Health Risks and Symptoms to Know
Recalled implants carry risks beyond cancer. Although the 2023 updates centered on cancer, patients may also face mechanical problems, immune reactions or symptoms often called “Breast Implant Illness.”
Primary health concerns: BIA-ALCL, squamous cell carcinoma, Breast Implant Illness symptoms, capsular contracture and mechanical failure such as rupture.
Warning Signs of BIA-ALCL
BIA-ALCL most often shows up as a “late seroma,” fluid that collects around the implant years after surgery, usually around 8 years after implantation, though it can appear anywhere from 2 to 28 years later.
Watch for: new swelling months or years after surgery, fluid that does not go away, lumps in the breast or armpit, breasts becoming uneven over time, pain near the implant and changes in the skin of the breast.
It usually starts in one breast. Caught early and treated by removing the implant and the entire capsule, BIA-ALCL has a 93% disease-free survival rate at three years.
SCC and Other Rare Tumors Near Implants
SCC forms in the capsule tissue and can take much longer to emerge, 7 to 42 years after implantation. Unlike BIA-ALCL, it has been reported with both smooth and textured implants.
Possible SCC symptoms: ongoing pain around the implant, open sores on the skin, hard lumps in the breast, changes in breast size or shape, and discolored or thickened skin.
The FDA’s archived SCC communication helps doctors spot these rare cancers. Any lasting, unexplained symptoms near an implant warrant a medical visit, particularly if you have had implants for many years.
Steps to Take If Your Implant Is Part of the Recall
Learning your implants were recalled can be unsettling, but keep this in mind: the FDA does not recommend hurrying to remove recalled implants when you have no symptoms.
Start by finding your implant card, which lists the manufacturer, model and serial numbers. If it is lost, ask your surgeon’s office for your operative report and implant information.
Then: request your complete records from the surgeon’s office, compare your implants with FDA recall lists, book a visit to talk about monitoring and report any symptoms through the FDA’s MedWatch program.
Should You Remove Recalled Implants If You Feel Fine?
The FDA’s guidance is direct: removal is not recommended without symptoms. Personal factors still matter, though; being over 46 and having implants longer than six years both raise risk.
Some people choose removal for peace of mind, while others prefer regular monitoring. Options include removal without replacement, switching to smooth implants or different extents of capsule removal.
How to Verify and Report Step by Step
Collect records: Ask your surgeon’s office for your full surgical file. Check official lists: Use FDA databases and manufacturer sites to confirm recall status. Book a consultation: Review your situation with your doctors. Keep notes: Save copies of records and track any changes. Report issues: File any symptoms through the FDA’s MedWatch system.
If you have had complications, consider talking to an attorney who handles medical device cases. Legal Lawsuit connects patients with experienced breast implant attorneys in our network through a free, confidential case review. Learn more about breast implant lawsuits.
Legal and Financial Options After the Breast Implant Recall
Knowing your legal and financial options matters. Most breast implant suits against Allergan are consolidated in MDL 2921 in federal court in New Jersey, with more than 1,200 cases still active by a recent count.
Allergan’s warranty program provides replacement implants and some limited coverage, but it does not pay for pain and suffering, lost income or emotional harm. The Women’s Health and Cancer Rights Act requires most health plans to cover complications of breast reconstruction.
How Breast Implant Claims and Settlements Work
The litigation focuses on failure to warn about cancer risk, design defects in textured surfaces and negligent post-market monitoring. Useful evidence includes medical records, pathology reports, imaging and treatment records.
Settlement value differs from case to case and depends on factors such as whether BIA-ALCL or another cancer was diagnosed, the treatment required, whether removal was preventive, and the strength of the medical records. Filing deadlines differ by state, so do not assume your window has closed.
Options After Implant Removal
Smooth implants are still widely used and have strong safety records. Fat transfer uses your own tissue for a natural result. Going flat is increasingly accepted, with active support communities. Combined approaches mix techniques to get the best outcome.
Choose a board-certified plastic surgeon experienced in reconstruction after removal. For legal help, Legal Lawsuit connects patients with experienced medical device attorneys in our network across all 50 states. See the Breast Implant Class Action Settlement page for more details.
Breast Implant Recall FAQs
Which brands and models does the 2023 update cover?
The 2023 updates added new safety information to the original 2019 Allergan recall; no new devices were recalled. The affected products remain Allergan’s Biocell textured implants: Natrelle saline and silicone models, the Natrelle Inspira line, Natrelle 410 implants and tissue expanders.
What changed in 2023 was the recognition that cancer risk is not limited to the recalled textured implants. The 19 SCC cases involved both smooth and textured implants from several manufacturers.
Do I need an MRI or ultrasound if I have no symptoms?
The FDA does not mandate monitoring, but many doctors recommend it for recalled implants. Ultrasound is often the first option because it costs less and detects fluid well, and many physicians suggest one each year, particularly once implants are more than six years old.
MRI is the best tool for finding silent ruptures but is more expensive. Many specialists suggest an MRI every 2-3 years or whenever an ultrasound raises questions, with your age and risk factors shaping how often you are checked.
Will Allergan or my insurer pay for removal?
Allergan’s warranty program provides free replacement implants and limited diagnostic coverage, but its help with surgical costs falls short for many patients, and it does not cover pain and suffering, lost income or other damages.
Insurance coverage differs. Cancer or a ruptured implant usually counts as medically necessary, while preventive removal is harder to get approved. The Women’s Health and Cancer Rights Act gives reconstruction patients leverage to seek coverage.
Out-of-pocket costs can be significant depending on your surgeon, location and coverage. Plan as though you may pay yourself, and treat any warranty or insurance help as a bonus.
Conclusion
The breast implant recall remains an active patient safety issue for thousands of people worldwide, and the cancer data released in 2023 reshaped what is known about textured implant risk.
Concern that began with BIA-ALCL now includes squamous cell carcinoma and other risks. The figures are serious, with 1,264 BIA-ALCL cases and 63 deaths reported plus 19 SCC cases in 2023, yet millions of people have textured implants and most will never develop cancer.
Bottom line: The recall covers specific Allergan textured implants, not every breast implant. The FDA still advises against rushing to remove recalled implants without symptoms, but recommends staying alert through monitoring.
What to do next: Confirm whether your implants were recalled, set up monitoring with your doctor, learn the warning signs of BIA-ALCL and SCC and keep thorough records. Try not to let worry take over; focus on the facts and work with qualified professionals.
Legal options are still open for people harmed by recalled implants. The multidistrict litigation continues and new cases are still being filed, so a BIA-ALCL or SCC diagnosis, or another serious complication, may entitle you to compensation.
Legal Lawsuit connects patients with experienced medical device attorneys in our network nationwide who understand the complexities of breast implant cases.
Whether you are facing a cancer diagnosis, weighing preventive removal or simply want to know your rights, a free, confidential case review can point you to the right attorney. For more, visit the personal injury lawsuits page.
Looking ahead, expect more safety research, continuing litigation and possibly new FDA guidance. Stay informed without letting fear make decisions for you: work with qualified providers, keep good records and remember that the choices about your health and legal options are yours.
You do not have to work through this alone. Help is available to support the best decision for your situation.
Related Posts
Quick Answer: The Boy Scouts of America (BSA) filed for Chapter 11 bankruptcy in 2020 after facing tens of thousands [...]
Quick Answer: Survivors of sexual abuse by Catholic priests, nuns, or other Church personnel may be able to file a [...]
Quick Answer: Clergy abuse settlements vary enormously based on the severity of the abuse, the strength of evidence that the [...]
